1. 1692PPhysicians' knowledge, attitudes and practice towards fertility and pregnancy-related issues in BRCA-mutated breast cancer (BC) patients (pts): Results from the BCY3/BCC 2017 survey. (23rd October 2018) Authors: Lambertini, M; Di Maio, M; Poggio, F; Pagani, O; Curigliano, G; Del Mastro, L; Paluch-Shimon, S; Loibl, S; Partridge, A H; Azim, H A; Peccatori, F A; Demeestere, I Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 242PImpact of deleterious germline BRCA mutations, addition of taxanes and use of adjuvant endocrine therapy (ET) on anti-müllerian hormone (AMH) levels in early breast cancer (EBC) patients treated by adjuvant chemotherapy (CT). (23rd October 2018) Authors: Olympios, N; Lambertini, M; Calbrix, C; Saint-Ghislain, M; Fontanilles, M; Loeb, A; Leheurteur, M; Demeestere, I; Di Fiore, F; Perdrix, A; Clatot, F Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 247PShould anthracyclines always be present in the adjuvant treatment of breast cancer (BC)? A systematic review and meta-analysis of randomized controlled trials (RCTs). (23rd October 2018) Authors: Caparica, R; Bruzzone, M; Poggio, F; Ceppi, M; de Azambuja, E; Lambertini, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 289PDLucitanib for the treatment of HR+ HER2- metastatic breast cancer (MBC) patients (pts): Results from the multicohort phase II FINESSE trial. (23rd October 2018) Authors: Hui, R; Pearson, A; Cortes Castan, J; Campbell, C; Poirot, C; Azim, H A; Fumagalli, D; Lambertini, M; Daly, F; Arahmani, A; Perez-Garcia, J; Aftimos, P G; Bedard, P; Xuereb, L; Loibl, S; Loi, S; Pierrat, M-J; Turner, N C; André, F; Curigliano, G Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 326PEffectiveness of trastuzumab emtansine (TDM1) in patients with HER2-positive advanced breast cancer (ABC) progressing after taxane plus pertuzumab plus trastuzumab. (23rd October 2018) Authors: Conte, B; Fabi, A; Poggio, F; Blondeaux, E; Dellepiane, C; D'Alonzo, A; Staiano, A; Buono, G; Arpino, G; Magri, V; Naso, G; Presti, D; Mura, S; Fontana, A; Cognetti, F; Molinelli, C; Pastorino, S; Bighin, C; Lambertini, M; Del Mastro, L Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 86ODose-dense adjuvant chemotherapy in early breast cancer: 15–year results of the phase III Mammella InterGruppo (MIG)-1 study. (13th May 2019) Authors: Blondeaux, E; Cantore, M; Michelotti, A; Conte, B; Benasso, M; Bighin, C; Lambertini, M; Poggio, F; Del Mastro, L Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 90OThe role of dose-dense (DD) adjuvant chemotherapy (CT) in HER2-positive (HER2+) early breast cancer (BC) patients (pts) before and after the introduction of trastuzumab (T): Exploratory analysis of the GIM2 trial. (13th May 2019) Authors: Lambertini, M; Bruzzone, M; Poggio, F; Conte, B; de Azambuja, E; Bisagni, G; De Laurentiis, M; de Placido, S; Cognetti, F; Del Mastro, L Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis. (8th October 2019) Authors: Ferreira, A R; Di Meglio, A; Pistilli, B; Gbenou, A S; El-Mouhebb, M; Dauchy, S; Charles, C; Joly, F; Everhard, S; Lambertini, M; Coutant, C; Cottu, P; Lerebours, F; Petit, T; Dalenc, F; Rouanet, P; Arnaud, A; Martin, A; Berille, J; Ganz, P A Journal: Annals of oncology Issue: Volume 30:Number 11(2019) Page Start: 1784 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial. Issue 12 (December 2022) Authors: Del Mastro, Lucia; Poggio, Francesca; Blondeaux, Eva; De Placido, Sabino; Giuliano, Mario; Forestieri, Valeria; De Laurentiis, Michelino; Gravina, Adriano; Bisagni, Giancarlo; Rimanti, Anita; Turletti, Anna; Nisticò, Cecilia; Vaccaro, Angela; Cognetti, Francesco; Fabi, Alessandra; Gasparro, Simon... Journal: Lancet oncology Issue: Volume 23:Issue 12(2022) Page Start: 1571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Impact of ARTs on oncological outcomes in young breast cancer survivors. Issue 2 (8th December 2020) Authors: Condorelli, M; De Vos, M; Lie Fong, S; Autin, C; Delvigne, A; Vanden Meerschaut, F; Wyns, C; Imbert, R; Cheruy, C; Bouziotis, J; de Azambuja, E; Delbaere, A; Lambertini, M; Demeestere, I Journal: Human reproduction Issue: Volume 36:Issue 2(2021) Page Start: 381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗